News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Immunicum Doses the First Patient in a New Clinical Phase I/II-Study in Primary Liver Cancer


10/23/2013 9:42:49 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Gothenburg, Sweden, 2013-10-23 12:27 CEST (GLOBE NEWSWIRE) -- The first patient in Immunicum’s clinical phase I/II-study in primary liver cancer today received the initial dose of the therapeutic cancer vaccine INTUVAX®. The Company is also finalizing a clinical phase I/II-study in metastatic renal cell carcinoma, initiated in February 2012 and thus far showing promising data.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES